Evidence map›Paper›PMID 35042901›Full record

ArticleScientific reports2022

Mutations affecting the N-terminal domains of SHANK3 point to different pathomechanisms in neurodevelopmental disorders.

Daniel Woike, Emily Wang, Debora Tibbe, Fatemeh Hassani Nia, Antonio Virgilio Failla, Maria Kibæk, Tinett Martesen Overgård, Martin J Larsen, Christina R Fagerberg, Igor Barsukov and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Daniel WoikeInstitute for Human Genetics, University Medical Center Hamburg Eppendorf, Hamburg, Germany.
Emily WangInstitute of Integrative Biology, University of Liverpool, Liverpool, UK.
Debora TibbeInstitute for Human Genetics, University Medical Center Hamburg Eppendorf, Hamburg, Germany.
Fatemeh Hassani NiaInstitute for Human Genetics, University Medical Center Hamburg Eppendorf, Hamburg, Germany.
Antonio Virgilio FaillaUKE Microscopic Imaging Facility (UMIF), University Medical Center Hamburg Eppendorf, Hamburg, Germany.
Maria KibækH C Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.
Tinett Martesen OvergårdDepartment of Psychiatry, Middelfart, Region of Southern Denmark, Denmark.
Martin J LarsenH C Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.
Christina R FagerbergH C Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.
Igor BarsukovInstitute of Integrative Biology, University of Liverpool, Liverpool, UK.
Hans-Jürgen KreienkampInstitute for Human Genetics, University Medical Center Hamburg Eppendorf, Hamburg, Germany. Kreienkamp@uke.de.
Universität Hamburg · DEOdense University Hospital · DKUniversity of Liverpool · GBRegion of Southern Denmark · DKUniversity Medical Center Hamburg-Eppendorf · DE

Funding

Biotechnology and Biological Sciences Research CouncilDeutsche Forschungsgemeinschaft 1321/9-1
6 · The paper itself

Abstract

Shank proteins are major scaffolds of the postsynaptic density of excitatory synapses. Mutations in SHANK genes are associated with autism and intellectual disability. The effects of missense mutations on Shank3 function, and therefore the pathomechanisms are unclear. Several missense mutations in SHANK3 affect the N-terminal region, consisting of the Shank/ProSAP N-terminal (SPN) domain and a set of Ankyrin (Ank) repeats. Here we identify a novel SHANK3 missense mutation (p.L270M) in the Ankyrin repeats in patients with an ADHD-like phenotype. We functionally analysed this and a series of other mutations, using biochemical and biophysical techniques. We observe two major effects: (1) a loss of binding to δ-catenin (e.g. in the p.L270M variant), and (2) interference with the intramolecular interaction between N-terminal SPN domain and the Ank repeats. This also interferes with binding to the α-subunit of the calcium-/calmodulin dependent kinase II (αCaMKII), and appears to be associated with a more severe neurodevelopmental pathology.

Indexed as

Mutation, MissenseNerve Tissue ProteinsNeurodevelopmental DisordersAnkyrin RepeatCalcium-Calmodulin-Dependent Protein Kinase Type 2ChildFemaleHumansMaleProtein BindingProtein DomainsCalcium-Calmodulin-Dependent Protein Kinase Type 2Nerve Tissue ProteinsSHANK3 protein, human

Identifiers

PMID35042901
PMCPMC8766471
OpenAlexW4225548386

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.